Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 6/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21596552 | 1.00 | LMNA (0.38) | LMNAHTR2ACHRNA7TDP1TP53 | |
| SCHEMBL8057322 | 0.87 | HTR2A (0.42) | LMNAHTR2ACHRNA7TDP1TP53 | |
| SCHEMBL4905648 | 0.83 | TP53 (0.39) | LMNAHTR2ACHRNA7TDP1TP53 | |
| SCHEMBL8382100 | 0.83 | TP53 (0.39) | LMNAHTR2ACHRNA7TDP1TP53 | |
| SCHEMBL21596607 | 0.78 | ALOX15 (0.47) | TDP1 | |
| SCHEMBL21596606 | 0.78 | ALOX15 (0.47) | TDP1 | |
| SCHEMBL24691226 | 0.76 | LMNA (0.59) | LMNATDP1 | |
| SCHEMBL24691968 | 0.76 | LMNA (0.59) | LMNATDP1 | |
| SCHEMBL13686299 | 0.74 | MAOB (0.48) | LMNACHRNA7MAPTSMN1; SMN2CYP2D6 | |
| SCHEMBL5670358 | 0.73 | NPC1 (0.45) | LMNAHTR2ACHRNA7TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257678-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-08-17 | — | — | US | disclosed |
| EP-3746420-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-08-16 | — | — | EP | disclosed |
| US-11667869-B2 | Enol ether pro perfume | FIRMENICH SA (CH) | 2023-06-06 | — | — | US | disclosed |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-04-22 | — | — | US | disclosed |
| EP-3746420-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2020-12-09 | — | — | EP | disclosed |
| WO-2019243501-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667869-B2 | Enol ether pro perfume | CYP2E1, ACADM, PEF1 | LMNA 268/4885HTR2A 3462/4885CHRNA7 2432/4885 |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | LMNA 1878/4885HTR2A 4154/4885CHRNA7 2343/4885 |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | CYP2E1, ACADM, ALDH5A1 | LMNA 776/4885HTR2A 4145/4885CHRNA7 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.